Literature DB >> 20855944

Recognition of p63 by the E3 ligase ITCH: Effect of an ectodermal dysplasia mutant.

A Bellomaria1, Gaetano Barbato, G Melino, M Paci, Sonia Melino.   

Abstract

The E3 ubiquitin ligase Itch mediates the degradation of the p63 protein. Itch contains four WW domains which are pivotal for the substrate recognition process. Indeed, this domain is implicated in several signalling complexes crucially involved in human diseases including Muscular Dystrophy, Alzheimer's Disease and Huntington Disease. WW domains are highly compact protein-protein binding modules that interact with short proline-rich sequences. The four WW domains present in Itch belong to the Group I type, which binds polypeptides with a PY motif characterized by a PP xY consensus sequence, where x can be any residue. Accordingly, the Itch-p63 interaction results from a direct binding of Itch-WW2 domain with the PY motif of p63. Here, we report a structural analysis of the Itch-p63 interaction by fluorescence, CD and NMR spectroscopy. Indeed, we studied the in vitro interaction between Itch-WW2 domain and p63(534-551), an 18-mer peptide encompassing a fragment of the p63 protein including the PY motif. In addition, we evaluated the conformation and the interaction with Itch-WW2 of a site specific mutant of p63, I549T, that has been reported in both Hay-Wells syndrome and Rapp-Hodgkin syndrome. Based on our results, we propose an extended PP xY motif for the Itch recognition motif (P-P-P-Y-x(4)-[ST]-[ILV]), which includes these C-terminal residues to the PP xY motif.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20855944

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  27 in total

1.  Special AT-rich binding protein-2 (SATB2) differentially affects disease-causing p63 mutant proteins.

Authors:  Jacky Chung; R Ian Grant; David R Kaplan; Meredith S Irwin
Journal:  J Biol Chem       Date:  2011-09-29       Impact factor: 5.157

2.  Recognition mechanism of p63 by the E3 ligase Itch: novel strategy in the study and inhibition of this interaction.

Authors:  Alessia Bellomaria; Gaetano Barbato; Gerry Melino; Maurizio Paci; Sonia Melino
Journal:  Cell Cycle       Date:  2012-08-30       Impact factor: 4.534

3.  TAp63 regulates bone remodeling by modulating the expression of TNFRSF11B/Osteoprotegerin.

Authors:  Anna Maria Lena; Erica Foffi; Massimiliano Agostini; Mara Mancini; Margherita Annicchiarico-Petruzzelli; Daniel Aberdam; Tania Velletri; Yufang Shi; Gerry Melino; Ying Wang; Eleonora Candi
Journal:  Cell Cycle       Date:  2021-11-11       Impact factor: 4.534

4.  Distinct interactors define the p63 transcriptional signature in epithelial development or cancer.

Authors:  Rosalba Pecorari; Francesca Bernassola; Gerry Melino; Eleonora Candi
Journal:  Biochem J       Date:  2022-06-30       Impact factor: 3.766

Review 5.  Integrating animal models and in vitro tissue models to elucidate the role of desmosomal proteins in diseases.

Authors:  Maranke I Koster; Jason Dinella; Jiangli Chen; Charlene O'Shea; Peter J Koch
Journal:  Cell Commun Adhes       Date:  2014-02

Review 6.  Modeling AEC-New approaches to study rare genetic disorders.

Authors:  Peter J Koch; Jason Dinella; Mary Fete; Elaine C Siegfried; Maranke I Koster
Journal:  Am J Med Genet A       Date:  2014-03-24       Impact factor: 2.802

7.  High throughput screening for inhibitors of the HECT ubiquitin E3 ligase ITCH identifies antidepressant drugs as regulators of autophagy.

Authors:  M Rossi; B Rotblat; K Ansell; I Amelio; M Caraglia; G Misso; F Bernassola; C N Cavasotto; R A Knight; A Ciechanover; G Melino
Journal:  Cell Death Dis       Date:  2014-05-01       Impact factor: 8.469

8.  p63 threonine phosphorylation signals the interaction with the WW domain of the E3 ligase Itch.

Authors:  Sonia Melino; Alessia Bellomaria; Ridvan Nepravishta; Maurizio Paci; Gerry Melino
Journal:  Cell Cycle       Date:  2014       Impact factor: 4.534

9.  Bispecific antibodies come to the aid of cancer immunotherapy.

Authors:  Ivano Amelio; Gerry Melino; Arnold J Levine
Journal:  Mol Oncol       Date:  2021-05-14       Impact factor: 6.603

10.  Analysis of large phenotypic variability of EEC and SHFM4 syndromes caused by K193E mutation of the TP63 gene.

Authors:  Jianhua Wei; Yang Xue; Lian Wu; Jie Ma; Xiuli Yi; Junrui Zhang; Bin Lu; Chunying Li; Dashuang Shi; Songtao Shi; Xinghua Feng; Tao Cai
Journal:  PLoS One       Date:  2012-05-04       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.